Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Interest & Investment Income (2023 - 2025)

Rallybio's Interest & Investment Income history spans 3 years, with the latest figure at $462000.0 for Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 53.14% year-over-year to $462000.0; the TTM value through Sep 2025 reached $2.4 million, down 49.72%, while the annual FY2024 figure was $4.2 million, 31.41% down from the prior year.
  • Interest & Investment Income for Q3 2025 was $462000.0 at Rallybio, down from $523000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $1.6 million in Q2 2023 and bottomed at $462000.0 in Q3 2025.
  • The 3-year median for Interest & Investment Income is $1.1 million (2024), against an average of $1.1 million.
  • The largest annual shift saw Interest & Investment Income fell 17.46% in 2024 before it crashed 54.24% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at $1.4 million in 2023, then tumbled by 43.99% to $811000.0 in 2024, then tumbled by 43.03% to $462000.0 in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Interest & Investment Income are $462000.0 (Q3 2025), $523000.0 (Q2 2025), and $644000.0 (Q1 2025).